Second Sight eyes $10M funding round | Wall Street Beat
Second Sight Medical registers for a $10 million funding round to back its Argus II 'bionic eye' retinal implant.
Second Sight Medical is hoping to raise $10.5 million, according to a regulatory filing, as it brings its "bionic eye" Argus II retinal implant to the U.S. market.
The device, comprised of an eyeglass-mounted camera and an electrical stimulator implanted in the eye, works by converting video images captured by a miniature camera housed in the patient's glasses into a series of small electrical pulses that are transmitted wirelessly to an array of electrodes on the surface of the retina.
The Sylmar, Calif.-based medical device company won pre-market approval from the FDA for the Argus II in February.